Tenax Therapeutics (TENX) Treasury Shares (2012 - 2018)

Tenax Therapeutics (TENX) posted quarterly Treasury Shares of $19914.0 for Q4 2018, little changed on a QoQ basis from $19914.0 in Q3 2018.

Tenax Therapeutics (TENX) Treasury Shares (2012 - 2018) Analysis & Trends

Tenax Therapeutics has reported Treasury Shares for 7 years, with the latest figure at $19914.0 in Q4 2018.

Treasury Shares for Q4 2018 came in at $19914.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $19914.0 (changed N/A YoY), and the FY2018 annual result was $19914.0, changed N/A from the prior year.
Treasury Shares held at $19914.0 in Q4 2018, from $19914.0 in the prior quarter.
Over five years, Treasury Shares peaked at $42629.0 in Q1 2014 and troughed at $12.0 in Q4 2016.
A 5-year average of $11932.5 and a median of $367.0 in 2016 frame the typical range for Treasury Shares.
The widest annual swing landed in 2014, when Treasury Shares soared 2115.86%; it then sank 99.79% in 2015.
A 5-year view of Treasury Shares shows it stood at $229.0 in 2014, then sank by 91.27% to $20.0 in 2015, then tumbled by 40.0% to $12.0 in 2016, then soared by 783.33% to $106.0 in 2017, then soared by 18686.79% to $19914.0 in 2018.
Per Business Quant data, the three most recent Treasury Shares figures were $19914.0 in Q4 2018, $19914.0 in Q3 2018, and $39828.0 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	Tenax Therapeutics	78.47 Mn	78.47 Mn	-	-

Download Data